Capricor Therapeutics Long-term Debt / Capital 2010-2024 | CAPR
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED PRODUCTS | $0.542B | $0.022B |
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. |